Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
about
RANK is essential for osteoclast and lymph node developmentThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisHIV: inflammation and boneSmad-dependent mechanisms of inflammatory bone destructionTranscriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expressionAnabolic effects of a G protein-coupled receptor kinase inhibitor expressed in osteoblastsBone regeneration and stem cellsAberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.Genetic disorders of the skeleton: a developmental approachMultiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.The parathyroid hormone, its fragments and analogues--potent bone-builders for treating osteoporosis.The potential role of bisphosphonates in prostate cancer.Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.Response of a preosteoblastic cell line to cyclic tensile stress conditioning and growth factors for bone tissue engineering.Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors.TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 ExpressionB cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivoEffect of TGF-β1 Stimulation on the Secretome of Human Adipose-Derived Mesenchymal Stromal Cells.Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiationDexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells.The role of the immune system in the pathophysiology of osteoporosis.Rheumatic diseases: the effects of inflammation on bone.Unique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL.TGF-beta1 on osteoimmunology and the bone component cellsSmad4 is required for maintaining normal murine postnatal bone homeostasisBreast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact.The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.Pathogenesis of age-related bone loss in humansSmad4 is required to inhibit osteoclastogenesis and maintain bone mass.Transforming growth factor-beta1 (TGF-beta1) induces human osteoclast apoptosis by up-regulating Bim.TGF-β and Physiological Root Resorption of Deciduous Teeth.Osteoclastogenesis and arthritis.How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis?Corticosteroid-induced osteoporosis: an update for dermatologists.Role of periodontal ligament fibroblasts in osteoclastogenesis: a review.The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.The osteoimmunology of alveolar bone loss.
P2860
Q24598872-424A9BE0-1124-4664-A653-5B81B06D86BBQ26773017-3E4DBF87-D1B1-4655-BEA6-3AFFB229701AQ27010898-FA4055FC-A93B-4F55-B59C-24E6F8B34AC9Q28066288-6317E559-418B-4402-8635-7BEE0AE8F21BQ28141671-FC7B4876-A49A-403B-936E-A26E36C23419Q28568727-7BF91F44-2C1B-4EA6-9C3F-EB28E1B6E5E5Q28659195-2AA7348D-4D76-4F45-A7E8-CA5958A8FD0EQ31149409-FD9C9DD4-88B2-4141-90EF-4C9BAB218FCEQ33782305-50237F4B-8E87-4E90-9493-231A6F25D3CBQ33906292-2DB2F3B3-D191-43BF-9F4B-EF0CE08591FFQ33944735-0314C82D-3AE2-42B5-B13B-0CBF31EC2920Q34074905-75B7542D-606B-4340-8BC7-0551C72AFE76Q35081743-6A53DF3D-8EEE-4E68-AD9A-5E087688555EQ35658848-B86CC52F-1EE9-47FD-A648-79F5918BD58FQ35706272-6E41FE30-C2F9-4AA0-A705-1EE89D085547Q35739984-58324D0A-4E8C-4B0E-8280-9338CC46293DQ35750113-34A8EDFF-088C-4E26-859B-565BFB30D76CQ35804512-D5D4C0FE-8B32-4C55-999D-15301116C850Q35878879-83240544-5987-4178-BC81-238E963C251BQ35991461-8CFABD23-E95D-41F3-91D3-4AF856922593Q36304388-E3337F9C-1250-4BC8-8C0B-6BBE88BB1580Q36324969-DF9E821A-54AA-46C6-8FA8-A51BC0C4D12CQ36324975-BBE531C7-F8E7-4A1C-A9C7-E4B3D1AD10B8Q36521118-B1C32342-B5CE-4F9F-8A92-05F40935944DQ36591727-2A3A567E-09F8-4273-9DBF-33C491CF5C76Q37217038-24CA101C-598F-4AC5-BD35-BE84777C4ED9Q37285702-8FE8D56A-B954-4B99-92EA-01B3DF8989FDQ37287589-1446AFD1-40F1-42F5-BA82-1F16F67A9294Q37305810-87EAF077-A230-4179-8BF6-142F114DEE32Q37330422-300D996E-8D6B-496B-AB88-1ED213FD0E05Q37358112-32C16197-7997-4FC5-9272-92F3CAE7B9FBQ37631450-8E097479-E1DF-432D-8EF3-2710B17000AEQ37808649-826C69F7-783A-4E0A-904F-86B55FBC3989Q37842633-20D57326-2EF3-4C68-9BB8-B941F7AD8600Q37990943-388C119D-BF9D-41CF-A2D3-1500DF5C35BFQ38215027-E616F46D-263D-4958-BE44-7D22A780D562Q38514990-ABA7027E-374F-4A25-BB99-3BBF3FC80737Q38636476-F90EEA56-81CE-4043-B317-6F89CC158BA0Q38699865-884019DE-B123-4F93-B5FE-5CAF42721E33Q38763612-F1B82551-3E56-4847-A54D-231E8B69379D
P2860
Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Transforming growth factor-bet ...... by bone marrow stromal cells.
@en
type
label
Transforming growth factor-bet ...... by bone marrow stromal cells.
@en
prefLabel
Transforming growth factor-bet ...... by bone marrow stromal cells.
@en
P2093
P2860
P356
P1476
Transforming growth factor-bet ...... by bone marrow stromal cells.
@en
P2093
Higashio K
Kanematsu M
Watanabe K
P2860
P304
27091-27096
P356
10.1074/JBC.273.42.27091
P407
P577
1998-10-01T00:00:00Z